Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units

被引:299
作者
Finfer, Simon [1 ]
Liu, Bette [1 ,2 ]
Taylor, Colman [1 ]
Bellomo, Rinaldo [3 ]
Billot, Laurent [1 ]
Cook, Deborah [4 ,5 ]
Du, Bin [6 ]
McArthur, Colin [7 ]
Myburgh, John [1 ]
机构
[1] George Inst Int Hlth, Crit Care & Trauma Div, Camperdown, NSW 2050, Australia
[2] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia
[3] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia
[4] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[5] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[6] Beijing Union Med Coll Hosp, Peking Union Med Coll, Med ICU, Beijing 100730, Peoples R China
[7] Auckland City Hosp, Dept Crit Care Med, Auckland 1023, New Zealand
来源
CRITICAL CARE | 2010年 / 14卷 / 05期
关键词
SEVERE SEPSIS; DEFINITIONS; MULTICENTER; STRATEGIES; COLLOIDS; ALBUMIN; THERAPY; INJURY; SALINE; SHOCK;
D O I
10.1186/cc9293
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Recent evidence suggests that choice of fluid used for resuscitation may influence mortality in critically ill patients. Methods: We conducted a cross-sectional study in 391 intensive care units across 25 countries to describe the types of fluids administered during resuscitation episodes. We used generalized estimating equations to examine the association between patient, prescriber and geographic factors and the type of fluid administered (classified as crystalloid, colloid or blood products). Results: During the 24-hour study period, 1,955 of 5,274 (37.1%) patients received resuscitation fluid during 4,488 resuscitation episodes. The main indications for administering crystalloid or colloid were impaired perfusion (1,526/3,419 (44.6%) of episodes), or to correct abnormal vital signs (1,189/3,419 (34.8%)). Overall, colloid was administered to more patients (1,234 (23.4%) versus 782 (14.8%)) and during more episodes (2,173 (48.4%) versus 1,468 (32.7%)) than crystalloid. After adjusting for patient and prescriber characteristics, practice varied significantly between countries with country being a strong independent determinant of the type of fluid prescribed. Compared to Canada where crystalloid, colloid and blood products were administered in 35.5%, 40.6% and 28.3% of resuscitation episodes respectively, odds ratios for the prescription of crystalloid in China, Great Britain and New Zealand were 0.46 (95% confidence interval (CI) 0.30 to 0.69), 0.18 (0.10 to 0.32) and 3.43 (1.71 to 6.84) respectively; odds ratios for the prescription of colloid in China, Great Britain and New Zealand were 1.72 (1.20 to 2.47), 4.72 (2.99 to 7.44) and 0.39 (0.21 to 0.74) respectively. In contrast, choice of fluid was not influenced by measures of illness severity (for example, Acute Physiology and Chronic Health Evaluation (APACHE) II score). Conclusions: Administration of resuscitation fluid is a common intervention in intensive care units and choice of fluid varies markedly between countries. Although colloid solutions are more expensive and may possibly be harmful in some patients, they were administered to more patients and during more resuscitation episodes than crystalloids were.
引用
收藏
页数:12
相关论文
共 17 条
  • [1] THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION
    BERNARD, GR
    ARTIGAS, A
    BRIGHAM, KL
    CARLET, J
    FALKE, K
    HUDSON, L
    LAMY, M
    LEGALL, JR
    MORRIS, A
    SPRAGG, R
    COCHIN, B
    LANKEN, PN
    LEEPER, KV
    MARINI, J
    MURRAY, JF
    OPPENHEIMER, L
    PESENTI, A
    REID, L
    RINALDO, J
    VILLAR, J
    VANASBECK, BS
    DHAINAUT, JF
    MANCEBO, J
    MATTHAY, M
    MEYRICK, B
    PAYEN, D
    PERRET, C
    FOWLER, AA
    SCHALLER, MD
    HUDSON, LD
    HYERS, T
    KNAUS, W
    MATTHAY, R
    PINSKY, M
    BONE, RC
    BOSKEN, C
    JOHANSON, WG
    LEWANDOWSKI, K
    REPINE, J
    RODRIGUEZROISIN, R
    ROUSSOS, C
    ANTONELLI, MA
    BELOUCIF, S
    BIHARI, D
    BURCHARDI, H
    LEMAIRE, F
    MONTRAVERS, P
    PETTY, TL
    ROBOTHAM, J
    ZAPOL, W
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) : 818 - 824
  • [2] RETRACTED: Volume replacement strategies on intensive care units: results from a postal survey (Retracted Article)
    Boldt, J
    Lenz, M
    Kumle, B
    Papsdorf, M
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (02) : 147 - 151
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] Intensive insulin therapy and pentastarch resuscitation in severe sepsis
    Brunkhorst, Frank M.
    Engel, Christoph
    Bloos, Frank
    Meier-Hellmann, Andreas
    Ragaller, Max
    Weiler, Norbert
    Moerer, Onnen
    Gruendling, Matthias
    Oppert, Michael
    Grond, Stefan
    Olthoff, Derk
    Jaschinski, Ulrich
    John, Stefan
    Rossaint, Rolf
    Welte, Tobias
    Schaefer, Martin
    Kern, Peter
    Kuhnt, Evelyn
    Kiehntopf, Michael
    Hartog, Christiane
    Natanson, Charles
    Loeffler, Markus
    Reinhart, Konrad
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) : 125 - 139
  • [5] Bunn F, 2008, COCHRANE DB SYST REV, V17
  • [6] Finfer S, 2004, NEW ENGL J MED, V350, P2247
  • [7] APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM
    KNAUS, WA
    DRAPER, EA
    WAGNER, DP
    ZIMMERMAN, JE
    [J]. CRITICAL CARE MEDICINE, 1985, 13 (10) : 818 - 829
  • [8] Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement
    Martin, GS
    Matthay, MA
    Abraham, ER
    Evans, TW
    Matuschak, GM
    Slutsky, AS
    Bhattacharya, J
    Dellinger, RP
    Dematte, JE
    Matthay, MA
    Sibbald, WJ
    Bernard, GR
    Cook, DJ
    Dubois, M
    Martin, GS
    Stewart, TE
    Vincent, JL
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (11) : 1247 - 1259
  • [9] Influences on physicians' choices of intravenous colloids
    Miletin, MS
    Stewart, TE
    Norton, PG
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (07) : 917 - 924
  • [10] Myburgh J, 2007, NEW ENGL J MED, V357, P874